Viking Therapeutics
Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VKTX
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A.
VKTX Key Statistics
VKTX News
Healthcare Viking Therapeutics shorts gain $0.5B amid selloff: report Aug. 20, 2025 6:54 AM ET Viking Therapeutics, Inc. (VKTX) Stock By: Dulan Lokuwithana, SA...
Viking Therapeutics Inc. VKTX saw its stock collapse by over 42% on Tuesday after data from its Phase 2 obesity pill trial disappointed investors, sparking a fi...
After Viking Therapeutics (VKTX) announced topline data from the Phase 2 VENTURE-Oral trial of oral VK2735 that showed “impressive” weight loss of up to 12.2% f...
Analyst ratings
88%
of 17 ratingsMore VKTX News
Viking Therapeutics (VKTX) stock dove on Tuesday following the release of data from a Phase 2 clinical trial of VK2735. This is the pharmaceutical company’s dua...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...